U.S. stocks rise in early trading after the Labor Department's PPI report matched expectations and showed that inflation is moderating. This raises investor's hopes of a rate cut later this year.
Drug-maker Amgen (AMGN | Quote | Chart | News | PowerRating) shares are down after the FDA voted to expand warnings on the company's anemia treatment drug, Aranesp. Amgen also received several downgrades this morning from HSBC Securities, JP Morgan, Citigroup, and Lazard Capital.
On the earnings front, Swedish truckmaker Volvo (VOLV | Quote | Chart | News | PowerRating) reported a 5.7% drop in first-quarter earnings. Volvo reported quarterly profits of $550.55 million. Telecom giant Alcatel-Lucent (ALU | Quote | Chart | News | PowerRating) posted a $10.8 million Q1 loss this morning. Shares are trading higher due to promises of a stronger Q2 and full year 2007. ALU was upgraded this morning by Credit Suisse from Neutral to Outperform.
For more stocks to watch, see TradingMarkets 7 Trading Ideas for Today.
Today's PowerRatings Heat Map has started to show more bullish signals after yesterday's selloff. Here is a snapshot of our Drug sector heat map, which is one of the strongest today:

Today's featured list comes from our PowerRatings Preferred Stock List. The PowerRatings Preferred List is comprised of momentum stocks with high PowerRatings (7-10) that have historically been widely held by major mutual funds, hedge funds, and momentum investors. Because these stocks tend to move rapidly, aggressive traders and investors find them highly atrractive. To learn more about the PowerRatings Preferred List and how to use it, click here.

For a free PowerRatings trial, click here. If you have any questions about PowerRatings or the new Stock Indicators please feel free to email us or call 213-955-5858 ext 1.
Darren Wong
Associate Editor
darrenw@tradingmarkets.com
Reminder: We are in no way recommending the purchase or short sale of these stocks. This article is intended for education purposes only. Trading should be based on your own understanding of market conditions, price patterns and risk; our information is designed to contribute to your understanding.